Ritter Pharmaceuticals, Inc. financial reports, Ritter Pharmaceuticals, Inc. annual revenue in 2024. When does Ritter Pharmaceuticals, Inc. report revenue?
Ritter Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue Ritter Pharmaceuticals, Inc. is now 0 $. Information about net revenue is taken from open sources. The dynamics of net revenue of Ritter Pharmaceuticals, Inc. rose. The change amounted to 0 $. The dynamics of net revenue is shown in comparison with the previous report. The dynamics of Ritter Pharmaceuticals, Inc. net income grew by 1 919 340 $ for the last reporting period. Ritter Pharmaceuticals, Inc. net income is shown in blue on the graph. All information on Ritter Pharmaceuticals, Inc. total revenue on this chart is created in the form of yellow bars. The value of Ritter Pharmaceuticals, Inc. assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2019
0 $
-
-4 705 766 $
-
31/12/2018
0 $
-
-6 625 106 $
-
30/09/2018
0 $
-
-4 646 262 $
-
30/06/2018
0 $
-
-3 584 652 $
-
31/03/2018
0 $
-
-2 012 690 $
-
31/12/2017
0 $
-
-2 216 747 $
-
30/09/2017
0 $
-
-2 010 852 $
-
30/06/2017
0 $
-
-1 963 024 $
-
Show:
to
Ritter Pharmaceuticals, Inc. financial report charts
The latest dates of Ritter Pharmaceuticals, Inc. financial statements available online: 30/06/2017, 31/12/2018, 31/03/2019. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Ritter Pharmaceuticals, Inc. for today is 31/03/2019. Gross profit Ritter Pharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Ritter Pharmaceuticals, Inc. is -48 625 $
Ritter Pharmaceuticals, Inc. quarterly report dates
Cost of revenue Ritter Pharmaceuticals, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Ritter Pharmaceuticals, Inc. is 48 625 $ Operating income Ritter Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Ritter Pharmaceuticals, Inc. is -4 777 057 $ Net income Ritter Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Ritter Pharmaceuticals, Inc. is -4 705 766 $
Current assets Ritter Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Ritter Pharmaceuticals, Inc. is 8 742 345 $ Total assets Ritter Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Ritter Pharmaceuticals, Inc. is 8 961 016 $ Current cash Ritter Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Ritter Pharmaceuticals, Inc. is 5 516 748 $
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-48 625 $
-33 978 $
-59 068 $
-48 263 $
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
48 625 $
33 978 $
59 068 $
48 263 $
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
-
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-4 777 057 $
-6 686 976 $
-4 663 499 $
-3 606 408 $
-2 038 662 $
-2 236 985 $
-2 014 935 $
-1 969 357 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-4 705 766 $
-6 625 106 $
-4 646 262 $
-3 584 652 $
-2 012 690 $
-2 216 747 $
-2 010 852 $
-1 963 024 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
3 574 855 $
5 185 510 $
3 459 681 $
1 871 242 $
849 683 $
752 286 $
915 268 $
774 476 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
4 777 057 $
6 686 976 $
4 663 499 $
3 606 408 $
2 038 662 $
2 236 985 $
2 014 935 $
1 969 357 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
8 742 345 $
15 277 017 $
12 962 360 $
16 792 992 $
19 094 128 $
22 799 371 $
3 819 471 $
5 761 701 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
8 961 016 $
15 319 902 $
12 994 310 $
16 826 405 $
19 126 964 $
22 833 570 $
4 160 189 $
5 792 948 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
5 516 748 $
7 812 259 $
12 496 576 $
16 254 455 $
18 917 043 $
22 631 971 $
3 558 874 $
5 415 298 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
4 061 542 $
5 933 518 $
2 553 435 $
1 910 340 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
18 917 043 $
22 631 971 $
3 558 874 $
5 415 298 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
4 132 396 $
5 933 518 $
2 553 435 $
1 910 340 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
46.12 %
38.73 %
19.65 %
11.35 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
209 097 $
1 310 129 $
7 096 666 $
10 674 082 $
18 325 900 $
20 125 982 $
1 202 314 $
3 009 965 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-6 544 960 $
-3 202 796 $
-3 757 879 $
-2 657 324 $
-3 714 928 $
-2 221 290 $
-1 545 638 $
-1 677 011 $
Last revenue report of Ritter Pharmaceuticals, Inc. was 31/03/2019. According to last financial report total revenue in Ritter Pharmaceuticals, Inc. was 0 US dollar and changed by 0% since last year. Net income in Ritter Pharmaceuticals, Inc. was -4 705 766 $ in last quartal, net income changes to 0%.
Current debt Ritter Pharmaceuticals, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Ritter Pharmaceuticals, Inc. is 4 061 542 $ Total debt Ritter Pharmaceuticals, Inc. is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt Ritter Pharmaceuticals, Inc. is 4 132 396 $ Cash flow Ritter Pharmaceuticals, Inc. is the net amount of cash and cash-equivalents being transferred into and out of a business. Cash flow Ritter Pharmaceuticals, Inc. is -6 544 960 $
Ritter Pharmaceuticals, Inc. stocks data
RTTR stock price
Ritter Pharmaceuticals, Inc. stock price today, RTTR stock quote.
